United States · Markets & Finance · MarketWatch

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

Published by MarketWatch · United States 9 h ago

Genmab shares jumped after the biotechnology company and partner AbbVie said their Epkinly drug helped extend the time patients with a common type of lymphoma lived without the…

Read the full article on MarketWatch Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)

Also worth reading

Business Insider

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

Quartz

These are the 10 U.S. cities with the most homes at risk of hurricane damage

OilPrice.com

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

Share

Also worth reading

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

At Least 50 Iranian Tankers Are Stuck in the Gulf as U.S. Blockade Holds